Cargando…

The DNA damage repair-related gene PKMYT1 is a potential biomarker in various malignancies

BACKGROUND: Protein kinase membrane associated tyrosine/threonine 1 (PKMYT1) regulates cell cycle and is a part of DNA damage repair (DDR)-related signaling. Recent studies have identified a role for PKMYT1 in tumor immunity and DDR. Thus, we initiated this study aiming to characterize the molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Changjian, Wang, Yuanyong, Pan, Minghong, Guo, Kai, Molnar, Tamas F., Kocher, Florian, Seeber, Andreas, Barr, Martin P., Navarro, Alfons, Han, Jing, Ma, Zhiqiang, Yan, Xiaolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743528/ https://www.ncbi.nlm.nih.gov/pubmed/35070764 http://dx.doi.org/10.21037/tlcr-21-973

Ejemplares similares

Targeting BRCA and DNA Damage Repair Genes in GI Cancers: Pathophysiology and Clinical Perspectives
por: Zimmer, Kai, et al.
Publicado: (2021)

The mitosis-related gene OIP5 is a potential biomarker in pan-cancer
por: Pan, Minghong, et al.
Publicado: (2023)

Mitosis-related gene CENP-U as a potential biomarker in malignancy
por: Shao, Changjian, et al.
Publicado: (2021)

Identification of the pyroptosis-related gene signature and risk score model for esophageal squamous cell carcinoma
por: Pan, Minghong, et al.
Publicado: (2023)

c-Myb-mediated inhibition of miR-601 in facilitating malignance of osteosarcoma via augmentation of PKMYT1
por: Luo, Peng, et al.
Publicado: (2022)

PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance
por: Zhang, Qi-Yong, et al.
Publicado: (2020)

PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
por: Long, Huan-ping, et al.
Publicado: (2020)

CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
por: Gallo, David, et al.
Publicado: (2022)

HDAC7/c-Myc signaling pathway promotes the proliferation and metastasis of choroidal melanoma cells
por: Zhang, Yimeng, et al.
Publicado: (2023)

Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
por: Schmidt, Matthias, et al.
Publicado: (2017)

PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis
por: Chen, Juan, et al.
Publicado: (2021)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
por: Wang, Yuanyong, et al.
Publicado: (2022)

Systematic expression analysis of WEE family kinases reveals the importance of PKMYT1 in breast carcinogenesis
por: Liu, Yu, et al.
Publicado: (2019)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma
por: Chen, Peng, et al.
Publicado: (2020)

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
por: Hu, Yiyang, et al.
Publicado: (2022)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

PKMYT1 regulates the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma cells by targeting CCNA2
por: Cai, Ye, et al.
Publicado: (2022)

Overexpression of PKMYT1 associated with poor prognosis and immune infiltration may serve as a target in triple-negative breast cancer
por: Li, Huihui, et al.
Publicado: (2023)

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Disseminated focal (18)F-fluoro-deoxyglucose uptake upon granulocyte colony-stimulating factor therapy mimicking malignant bone infiltration: case report of a patient with very severe aplastic anemia
por: Horvath, Lena, et al.
Publicado: (2020)

Synthetic lethal interaction between WEE1 and PKMYT1 is a target for multiple low-dose treatment of high-grade serous ovarian carcinoma
por: Benada, Jan, et al.
Publicado: (2023)

LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway
por: He, Yaomei, et al.
Publicado: (2021)

Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy
por: Ding, Peng, et al.
Publicado: (2022)

Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer
por: Shao, Changjian, et al.
Publicado: (2021)

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma
por: Liu, Honggang, et al.
Publicado: (2023)

The Prognostic Impact of Comorbidities in Patients with De-Novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP Immunochemotherapy in Curative Intent
por: Kocher, Florian, et al.
Publicado: (2020)

A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (Cohort Study)
por: Duan, Hongtao, et al.
Publicado: (2023)

Detection of epidermal growth factor receptor (EGFR) mutations from preoperative circulating tumor DNA (ctDNA) as a prognostic predictor for stage I–III non-small cell lung cancer (NSCLC) patients with baseline tissue EGFR mutations
por: Guo, Kai, et al.
Publicado: (2021)

Treatment According to Molecular Profiling in Relapsed/Refractory Cancer Patients: A Review Focusing on Latest Profiling Studies
por: Zimmer, Kai, et al.
Publicado: (2019)

Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures
por: Kocher, Florian, et al.
Publicado: (2021)

WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway
por: Feng, Yingtong, et al.
Publicado: (2022)

Survival analysis and development of a prognostic nomogram for patients with malignant mesothelioma in different anatomic sites
por: Shao, Shengteng, et al.
Publicado: (2022)

Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE)
por: Duan, Hongtao, et al.
Publicado: (2022)

Remodelers move chromatin in response to DNA damage
por: Seeber, Andrew, et al.
Publicado: (2014)

PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
por: Zimmer, Kai, et al.
Publicado: (2023)

PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair
por: Xie, Yinghai, et al.
Publicado: (2021)

Potential lethal damage repair in glioblastoma cells irradiated with ion beams of various types and levels of linear energy transfer
por: Chew, Ming Tsuey, et al.
Publicado: (2019)

DNA-Damage Foci to Detect and Characterize DNA Repair Alterations in Children Treated for Pediatric Malignancies
por: Schuler, Nadine, et al.
Publicado: (2014)

Responses to commentary on ‘Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: a systematic review and meta-analysis’ (Int J Surg 2022;106:106929)
por: Wang, Zhaoyang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_56j3t84lft4k8c5rob2p1t26vn